Your trusted source for investing success
By Jocelyn Aspa
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week’s NASDAQ biotech stock list.
By Micha Boon
Valens GroWorks Corp. (CSE:VGW) (“Valens GroWorks”, or the “Company”) is pleased to announce that its wholly owned subsidiary Valens Agritech Ltd. (“Valens”), a Health Canada Licensed Dealer, has signed a supply and sales agreement with Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”) for the distribution, marketing and sale of the
By Micha Boon
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce the close of its non-brokered private placement (the “Private Placement”) of 2,000,000 common shares (the “Shares”) at a price of C $0.25 per Share for gross proceeds of C $500,000 with ScreenCell SA (“ScreenCell”), announced October
By Micha Boon
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”) is pleased to announce a non-brokered private placement (the “Private Placement”) of 2,000,000 common shares (the “Shares”) at a price of C $0.25 per Share for gross proceeds of C $500,000 with ScreenCell SA (“ScreenCell”).
ScreenCell, a strategic partner to 3DS,
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“), a vertically integrated provider of cannabis products, is pleased to announce the closing of an additional 85,000 units (the “Units”) for proceeds of $85,000, the final tranche of its non-brokered $1.00 per Unit private placement (the “Offering”) first announced on July 26, 2017. The Offering
Zogenix, Aradigm, Vermillion, Aralez Pharmaceuticals and Kura Oncology top the NASDAQ biotech stock list.
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
Tetra Bio-Pharma appointed Bernard Fortier as new CEO, Andre Rancourt, previous interim CEO will take the position as Chairman of the Board of Directors.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
United Cannabis Corporation acquired a majority share of Prana Therapeutics.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
AVEO, leads the list of last week’s life science gainers on the NASDAQ, followed by BioDelivery Sciences, Dynavax, Catalyst and Ekso Bionics.
Naturally Splendid (TSXV:NSP) is pleased to announce its financial results for the first quarter ended March 31st, 2017. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards.
By Shelly Kumar
Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company’s subsidiary Northern Vine Canada Inc. (“Northern Vine”).
Ms. McCarthy brings more than 20 years of direct sales and marketing experience to the Company
Oncolytics Biotech announced the US Food and Drug Administration granted a fast track designation for Reolysin, an immuno-oncology viral agent treating metastatic breast cancer.
